Request for Covid-19 Impact Assessment of this Report
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
In the last several years, global market of Pneumococcal Vaccine developed rapidly generally, while global production growth rate of Pneumococcal Vaccine experienced slight fluctuations due to patent validity. In 2016, global production of Pneumococcal Vaccine is nearly 126 million doses. The Revenue of Pneumococcal Vaccine is around 6768 M in 2016.
Scope of the Report:
This report focuses on the Pneumococcal Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10
Market Segment by Applications, can be divided into
Child
Adult
There are 15 Chapters to deeply display the global Pneumococcal Vaccine market.
Chapter 1, to describe Pneumococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pneumococcal Vaccine, with sales, revenue, and price of Pneumococcal Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Vaccine, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview 1
1.1 Pneumococcal Vaccine Introduction 1
1.2 Market Analysis by Type 3
1.2.1 PPSV 23 4
1.2.2 PCV 7/13 4
1.2.3 PCV 10 5
1.3 Market Analysis by Applications 6
1.3.1 Child 6
1.3.2 Adult 7
1.4 Market Analysis by Regions 8
1.4.1 North America (USA, Canada and Mexico) 8
1.4.2 Europe (Germany, France, UK, Russia and Italy) 11
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 16
1.4.4 South America 21
1.4.5 Middle East and Africa 24
1.5 Market Dynamics 28
1.5.1 Market Opportunities 28
1.5.2 Market Risk 28
1.5.3 Market Driving Force 29
2 Manufacturers Profiles 30
2.1 Pfizer 30
2.1.1 Business Overview 30
2.1.2 Pneumococcal Vaccine Picture 31
2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 31
2.2 GSK 31
2.2.1 Business Overview 31
2.2.2 Pneumococcal Vaccine Product Picture 32
2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 33
2.3 MSD 33
2.3.1 Business Overview 33
2.3.2 Pneumococcal Vaccine Product Picture 34
2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 35
2.4 Sanofipasteur 35
2.4.1 Business Overview 35
2.4.2 Pneumococcal Vaccine Product Picture 36
2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 36
2.5 CDIBP 37
2.5.1 Business Overview 37
2.5.2 Pneumococcal Vaccine Product Picture 38
2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share 38
3 Global Pneumococcal Vaccine Market Competition, by Manufacturer 39
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer 39
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer 40
3.3 Market Concentration Rate 42
3.4 Market Competition Trend 42
4 Global Pneumococcal Vaccine Market Analysis by Regions 43
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions 43
4.1.1 Global Pneumococcal Vaccine Sales by Regions (2012-2017) 44
4.1.2 Global Pneumococcal Vaccine Revenue by Regions (2012-2017) 45
4.2 North America Pneumococcal Vaccine Sales and Growth (2012-2017) 47
4.3 Europe Pneumococcal Vaccine Sales and Growth (2012-2017) 48
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth (2012-2017) 49
4.5 South America Pneumococcal Vaccine Sales and Growth (2012-2017) 50
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth (2012-2017) 51
5 North America Pneumococcal Vaccine by Countries 52
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 52
5.1.1 North America Pneumococcal Vaccine Sales by Countries (2012-2017) 52
5.1.2 North America Pneumococcal Vaccine Revenue by Countries (2012-2017) 54
5.2 USA Pneumococcal Vaccine Sales and Growth (2012-2017) 56
5.3 Canada Pneumococcal Vaccine Sales and Growth (2012-2017) 57
5.4 Mexico Pneumococcal Vaccine Sales and Growth (2012-2017) 58
6 Europe Pneumococcal Vaccine by Countries 59
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 59
6.1.1 Europe Pneumococcal Vaccine Sales by Countries (2012-2017) 59
6.1.2 Europe Pneumococcal Vaccine Revenue by Countries (2012-2017) 61
6.2 Germany Pneumococcal Vaccine Sales and Growth (2012-2017) 63
6.3 UK Pneumococcal Vaccine Sales and Growth (2012-2017) 64
6.4 France Pneumococcal Vaccine Sales and Growth (2012-2017) 64
6.5 Russia Pneumococcal Vaccine Sales and Growth (2012-2017) 65
6.6 Italy Pneumococcal Vaccine Sales and Growth (2012-2017) 65
7 Asia-Pacific Pneumococcal Vaccine by Countries 66
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 66
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales by Countries (2012-2017) 66
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue by Countries (2012-2017) 68
7.2 China Pneumococcal Vaccine Sales and Growth (2012-2017) 70
7.3 Japan Pneumococcal Vaccine Sales and Growth (2012-2017) 71
7.4 Korea Pneumococcal Vaccine Sales and Growth (2012-2017) 72
7.5 India Pneumococcal Vaccine Sales and Growth (2012-2017) 73
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth (2012-2017) 74
8 South America Pneumococcal Vaccine by Countries 75
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 75
8.1.1 South America Pneumococcal Vaccine Sales by Countries (2012-2017) 75
8.1.2 South America Pneumococcal Vaccine Revenue by Countries (2012-2017) 77
8.2 Brazil Pneumococcal Vaccine Sales and Growth (2012-2017) 79
8.3 Argentina Pneumococcal Vaccine Sales and Growth (2012-2017) 80
8.4 Columbia Pneumococcal Vaccine Sales and Growth (2012-2017) 81
9 Middle East and Africa Pneumococcal Vaccine by Countries 82
9.1 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Countries 82
9.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries (2012-2017) 82
9.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2012-2017) 84
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth (2012-2017) 87
9.3 UAE Pneumococcal Vaccine Sales and Growth (2012-2017) 88
9.4 Egypt Pneumococcal Vaccine Sales and Growth (2012-2017) 89
9.5 Nigeria Pneumococcal Vaccine Sales and Growth (2012-2017) 90
9.6 South Africa Pneumococcal Vaccine Sales and Growth (2012-2017) 91
10 Global Pneumococcal Vaccine Market Segment by Type 92
10.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2012-2017) 92
10.1.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2012-2017) 92
10.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017) 92
10.2 PPSV 23 Sales Growth and Price 93
10.2.1 Global PPSV 23 Sales Growth (2012-2017) 93
10.2.2 Global PPSV 23 Price (2012-2017) 94
10.3 PCV 7/13 Sales Growth and Price 95
10.3.1 Global PCV 7/13 Sales Growth (2012-2017) 95
10.3.2 Global PCV 7/13 Price (2012-2017) 96
10.4 PCV 10 Sales Growth and Price 97
10.4.1 Global PCV 10 Sales Growth (2012-2017) 97
10.4.2 Global PCV 10 Price (2012-2017) 98
11 Global Pneumococcal Vaccine Market Segment by Application 99
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2012-2017) 99
11.2 Child Sales Growth (2012-2017) 100
11.3 Adult Sales Growth (2012-2017) 100
12 Pneumococcal Vaccine Market Forecast (2017-2022) 101
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022) 101
12.2 Pneumococcal Vaccine Market Forecast by Regions (2017-2022) 102
12.2.1 North America Pneumococcal Vaccine Market Forecast (2017-2022) 103
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2017-2022) 104
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2017-2022) 105
12.2.4 South America Pneumococcal Vaccine Market Forecast (2017-2022) 106
12.2.5 Middle East and Africa Pneumococcal Vaccine Market Forecast (2017-2022) 107
12.3 Pneumococcal Vaccine Market Forecast by Type (2017-2022) 107
12.4 Pneumococcal Vaccine Market Forecast by Application (2017-2022) 108
13 Sales Channel, Distributors, Traders and Dealers 109
13.1 Sales Channel 109
13.2 Distributors, Traders and Dealers 110
14 Research Findings and Conclusion 112
15 Appendix 113
15.1 Methodology 113
15.2 Analyst Introduction ??!??????
15.3 Data Source 114List of Tables and Figures
Figure Pneumococcal Vaccine Picture 1
Figure Specifications of PCV 13 2
Figure Specifications of PCV 10 2
Figure Specifications of PPSV 23 2
Figure Global Sales Market Share of Pneumococcal Vaccine by Types in 2016 3
Table Types of Pneumococcal Vaccine 3
Table Pneumococcal Vaccine Types for Major Manufacturers in 2016 3
Figure PPSV 23 Picture 4
Figure PCV 7/13 Picture 5
Figure PCV 10 Picture 5
Figure Pneumococcal Vaccine Sales Market Share by Applications in 2016 6
Table Applications of Pneumococcal Vaccine 6
Figure Child Picture 7
Figure Adult Picture 7
Figure USA Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 8
Figure Canada Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 9
Figure Mexico Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 10
Figure Germany Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 11
Figure France Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 12
Figure UK Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 13
Figure Russia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 14
Figure Italy Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 15
Figure China Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 16
Figure Japan Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 17
Figure Korea Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 18
Figure India Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 19
Figure Southeast Asia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 20
Figure Brazil Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 21
Figure Argentina Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 22
Figure Columbia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 23
Figure Saudi Arabia Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 24
Figure UAE Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 25
Figure Egypt Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 26
Figure Nigeria Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 27
Figure South Africa Pneumococcal Vaccine Revenue (M ) and Growth Rate (2012-2022) 28
Table Market Opportunities 28
Table Market Risk 28
Table Market Driving Force 29
Table Pfizer Basic Information 30
Figure Pneumococcal Vaccine Picture of Pfizer 31
Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 31
Table GSK Basic Information 31
Figure Pneumococcal Vaccine Product Picture of GSK 32
Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 33
Table MSD Basic Information 33
Figure Pneumococcal Vaccine Product Picture of MSD 34
Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 35
Table Sanofipasteur Basic Information 35
Figure Pneumococcal Vaccine Product Picture of Sanofipasteur 36
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 36
Table CDIBP Basic Information 37
Figure Pneumococcal Vaccine Product Picture of CDIBP 38
Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 38
Table Global Pneumococcal Vaccine Sales (K Doses) by Manufacturer (2016-2017) 39
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016 39
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017 40
Table Global Pneumococcal Vaccine Revenue (M ) by Manufacturer (2016-2017) 40
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016 41
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017 41
Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share 42
Figure Global Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 43
Figure Global Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 44
Table Global Pneumococcal Vaccine Sales (K Doses) by Regions (2012-2017) 44
Table Global Pneumococcal Vaccine Sales Market Share by Regions (2012-2017) 44
Table Global Pneumococcal Vaccine Revenue (M ) by Regions (2012-2017) 45
Table Global Pneumococcal Vaccine Revenue Market Share by Regions in 2012 45
Table Global Pneumococcal Vaccine Revenue Market Share by Regions in 2016 46
Figure North America Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 47
Figure Europe Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 48
Figure Asia-Pacific Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 49
Figure South America Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 50
Figure Middle East and Africa Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 51
Figure North America Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 52
Table North America Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 52
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 53
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2012 53
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2016 54
Table North America Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 54
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 54
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2012 55
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2016 55
Figure USA Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 56
Figure Canada Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 57
Figure Mexico Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 58
Figure Europe Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 59
Table Europe Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 59
Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 60
Figure Europe Pneumococcal Vaccine Sales Market Share by Countries in 2012 60
Figure Europe Pneumococcal Vaccine Sales Market Share by Countries in 2016 61
Table Europe Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 61
Table Europe Pneumococcal Vaccine Revenue Share by Countries (2012-2017) 61
Table Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2012 62
Table Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2016 63
Figure Germany Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 63
Figure UK Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 64
Figure France Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 64
Figure Russia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 65
Figure Italy Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 65
Figure Asia-Pacific Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 66
Table Asia-Pacific Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 66
Table Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 67
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries in 2012 67
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries in 2016 68
Table Asia-Pacific Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 68
Table Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 68
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries in 2012 69
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries in 2016 70
Figure China Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 70
Figure Japan Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 71
Figure Korea Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 72
Figure India Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 73
Figure Southeast Asia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 74
Figure South America Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 75
Table South America Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 75
Table South America Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 76
Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2012 76
Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2016 77
Table South America Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 77
Table South America Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 77
Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2012 78
Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2016 79
Figure Brazil Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 79
Figure Argentina Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 80
Figure Columbia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 81
Figure Middle East and Africa Pneumococcal Vaccine Revenue (M ) and Growth (2012-2017) 82
Table Middle East and Africa Pneumococcal Vaccine Sales (K Doses) by Countries (2012-2017) 82
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2012-2017) 83
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2012 83
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2016 84
Table Middle East and Africa Pneumococcal Vaccine Revenue (M ) by Countries (2012-2017) 84
Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017) 84
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2012 85
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2016 86
Figure Saudi Arabia Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 87
Figure UAE Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 88
Figure Egypt Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 89
Figure Nigeria Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 90
Figure South Africa Pneumococcal Vaccine Sales (K Doses) and Growth (2012-2017) 91
Table Global Pneumococcal Vaccine Sales (K Doses) by Type (2012-2017) 92
Table Global Pneumococcal Vaccine Sales Share by Type (2012-2017) 92
Table Global Pneumococcal Vaccine Revenue (M ) by Type (2012-2017) 92
Table Global Pneumococcal Vaccine Revenue Share by Type (2012-2017) 93
Figure Global PPSV 23 Sales Growth (2012-2017) 93
Figure Global PPSV 23 Price (/Dose) (2012-2017) 94
Figure Global PCV 7/13 Sales Growth (2012-2017) 95
Figure Global PCV 7/13 Price (/Dose) (2012-2017) 96
Figure Global PCV 10 Sales Growth (2012-2017) 97
Figure Global PCV 10 Price (/Dose) (2012-2017) 98
Table Global Pneumococcal Vaccine Sales (K Doses) by Application (2012-2017) 99
Table Global Pneumococcal Vaccine Sales Share by Application (2012-2017) 99
Figure Global Child Sales Growth (2012-2017) 100
Figure Global Adult Sales Growth (2012-2017) 100
Figure Global Pneumococcal Vaccine Sales (K Doses) and Growth Rate (2017 -2022) 101
Figure Global Pneumococcal Vaccine Revenue (M ) and Growth Rate (2017 -2022) 102
Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Regions (2017-2022) 102
Table Global Pneumococcal Vaccine Market Share Forecast by Regions (2017-2022) 102
Figure North America Sales Pneumococcal Vaccine Market Forecast (2017-2022) 103
Figure Europe Sales Pneumococcal Vaccine Market Forecast (2017-2022) 104
Figure Asia-Pacific Sales Pneumococcal Vaccine Market Forecast (2017-2022) 105
Figure South America Sales Pneumococcal Vaccine Market Forecast (2017-2022) 106
Figure Middle East and Africa Sales Pneumococcal Vaccine Market Forecast (2017-2022) 107
Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Type (2017-2022) 107
Table Global Pneumococcal Vaccine Market Share Forecast by Type (2017-2022) 107
Table Global Pneumococcal Vaccine Sales (K Doses) Forecast by Application (2017-2022) 108
Table Global Pneumococcal Vaccine Market Share Forecast by Application (2017-2022) 108
Table Distributors/Traders/ Dealers List 110
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...